RTW Investments’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155M Hold
4,869,798
1.32% 28
2026
Q1
$147M Hold
4,869,798
1.46% 22
2025
Q4
$169M Hold
4,869,798
1.69% 19
2025
Q3
$177M Hold
4,869,798
2.18% 15
2025
Q2
$153M Hold
4,869,798
2.18% 17
2025
Q1
$144M Hold
4,869,798
2.21% 16
2024
Q4
$144M Hold
4,869,798
2.17% 18
2024
Q3
$152M Hold
4,869,798
2.19% 20
2024
Q2
$165M Sell
4,869,798
-1,149,843
-19% -$58.6M 2.56% 16
2024
Q1
$391M Sell
6,019,641
-76,746
-1% -$5.27M 5.78% 2
2023
Q4
$417M Hold
6,096,387
6.51% 2
2023
Q3
$316M Buy
6,096,387
+66,754
+1% +$3.95M 6.68% 2
2023
Q2
$362M Buy
6,029,633
+379,690
+7% +$21.7M 6.88% 1
2023
Q1
$279M Buy
5,649,943
+90,621
+2% +$5.1M 5.82% 5
2022
Q4
$317M Buy
5,559,322
+1,107,839
+25% +$62.4M 6.48% 4
2022
Q3
$209M Buy
4,451,483
+455,329
+11% +$21.7M 4.82% 5
2022
Q2
$149M Buy
3,996,154
+2,136,683
+115% +$69.4M 3.85% 7
2022
Q1
$55.6M Buy
1,859,471
+613,939
+49% +$15.5M 1.15% 33
2021
Q4
$42.6M Hold
1,245,532
0.62% 50
2021
Q3
$46.2M Hold
1,245,532
0.7% 40
2021
Q2
$47.9M Hold
1,245,532
0.72% 37
2021
Q1
$50.1M Buy
+1,245,532
New +$55.5M 0.78% 40

Other funds holding IMCR

RTW Investments's IMCR Position: Q2 2026 in Review

RTW Investments held its Immunocore (IMCR) position steady in Q2 2026 at 4,869,798 shares worth $155M. The position accounts for 1.32% of the portfolio, ranked #28.

RTW Investments first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $417M in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • RTW Investments held 4,869,798 shares of Immunocore worth $155M as of Q2 2026.
  • RTW Investments left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up 1.32% of RTW Investments's portfolio in Q2 2026, its #28 holding.
  • RTW Investments first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • RTW Investments's Immunocore position peaked at $417M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.